Description
Entropro Instant Sachets contains, Streptococcus faecalis T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A which are patented prebiotic strains, licensed from TOA Pharmaceuticals Co. Ltd, Japan and Lactic acid bacillus (Lactobacillus sporogenes), which is a time tested probiotic strain. In the intestine, Streptococcus faecalis T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A present in BIFILAC proliferate through the process of symbiosis. Through this symbiotic action, they produce certain pathogens (Bad bacteria) inhibiting factors like Lactic acid, Short chain fatty acids like acetic acid and butyric acid. In addition, Bacillius mesentericus TO-A produces a nutrient which helps in increasing the count of beneficial bacteria in the intestine. Lactic acid bacillus (Lactobacillus sporogenes) present in BIFILAC is a spore-forming lactobacilli which produces lactic acid which has pathogen inhibiting ability. In addition, it also produces enzymes required in the digestion of various carbohydrates, fats, and proteins and also aids in their absorption.